Your browser doesn't support javascript.
loading
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
Findlow, Jamie; Borrow, Ray; Snape, Matthew D; Dawson, Tom; Holland, Ann; John, Tessa M; Evans, Anita; Telford, Karen L; Ypma, Ellen; Toneatto, Daniela; Oster, Philipp; Miller, Elizabeth; Pollard, Andrew J.
Affiliation
  • Findlow J; Vaccine Evaluation Unit, Health Protection Agency North West, Manchester Royal Infirmary, Manchester, UK. jamie.findlow@hpa.org.uk
Clin Infect Dis ; 51(10): 1127-37, 2010 Nov 15.
Article in En | MEDLINE | ID: mdl-20954968
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Outer Membrane Proteins / Meningococcal Vaccines / Neisseria meningitidis, Serogroup B / Meningitis, Meningococcal Type of study: Clinical_trials Limits: Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2010 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Outer Membrane Proteins / Meningococcal Vaccines / Neisseria meningitidis, Serogroup B / Meningitis, Meningococcal Type of study: Clinical_trials Limits: Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2010 Document type: Article Affiliation country: United kingdom Country of publication: United States